Related Experiment Video
Updated: Jul 17, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis
Marloes W Heijstek1, Gecilmara C S Pileggi, Evelien Zonneveld-Huijssoon
1Department of Paediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Room KC 03-0630, PO Box 85090, 3508 AB Utrecht, The Netherlands.
Objective:
To assess the effect of measles, mumps and rubella (MMR) vaccination on disease activity in children with juvenile idiopathic arthritis (JIA).
Methods:
A retrospective observational multicentre cohort study was performed in 314 patients with JIA, born between 1989 and 1996. Disease activity and medication use were compared during the period of 6 months before vaccination versus 6 months after vaccination. Disease activity was measured by joint counts, the Physician's global assessment scale and erythrocyte sedimentation rate. Next, we compared disease activity in patients vaccinated between 8 and 9 years of age with the activity in patients who had not been vaccinated at this time (who received MMR between the ages of 9 and 10 years).
Results:
No increase in disease activity or medication use was seen in the 6 months after MMR vaccination (n = 207), including in patients using methotrexate (n = 49). No overt measles infections were noted. When disease activity in vaccinated patients (n = 108) was compared with activity in those not yet vaccinated (n = 86), there were no significant differences.
Conclusions:
The MMR booster vaccination does not seem to aggravate disease activity in JIA. This indicates that the most patients with JIA can be vaccinated safely with the MMR vaccine. A prospective study is recommended.
Insights
Measles, mumps, and rubella (MMR) vaccination does not appear to worsen disease activity in children with juvenile idiopathic arthritis (JIA). This study suggests MMR vaccination is safe for most JIA patients.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Vaccinology
Background:
- Juvenile idiopathic arthritis (JIA) is a chronic autoimmune condition in children.
- Vaccination is crucial for immunocompromised individuals, but safety concerns sometimes arise.
Purpose of the Study:
- To evaluate the impact of measles, mumps, and rubella (MMR) vaccination on disease activity in pediatric patients with JIA.
- To determine if MMR vaccination exacerbates JIA symptoms or increases medication requirements.
Main Methods:
- Retrospective observational multicenter cohort study involving 314 JIA patients (born 1989-1996).
- Compared disease activity (joint counts, physician global assessment, ESR) and medication use 6 months before and after MMR vaccination.
- Compared disease activity between children vaccinated at 8-9 years versus those vaccinated later (9-10 years).
Main Results:
- No significant increase in JIA disease activity or medication use was observed in the 6 months post-MMR vaccination (n=207).
- This finding held true for patients on methotrexate (n=49).
- No significant differences in disease activity were found when comparing vaccinated (n=108) versus unvaccinated (n=86) patients at specific age intervals.
Conclusions:
- MMR booster vaccination does not appear to aggravate disease activity in children with JIA.
- The MMR vaccine can likely be administered safely to the majority of JIA patients.
- Further prospective studies are recommended to confirm these findings.
Related Concept Videos
Respiratory Syncytial Virus Disease
Vaccinations
Chickenpox
Arboviral Encephalitis
Cryptococcal Meningitis
Viral Meningitis
